Sheryl Merkin, M.S., F.N.P., C.D.E., Sharon Movsas, M.S., R.D., C.D.E., and Joel Zonszein, M.D., C.D.E.
Dr. Zonszein is Professor of Clinical Medicine, Albert Einstein College of Medicine. All authors are staff members of the Clinical Diabetes Center of Montefiore Medical Center, New York.
Within the past 12 months, Dr. Zonszein has been on the Speakers Bureau of Merck, Sanofi Aventis, Takeda Pharmaceuticals, Eli Lilly & Co. and Novo Nordisk; Ms. Merkin has been on the Speakers Bureau of Sanofi Aventis and Novo Nordisk; Ms. Movsas reports no commercial conflicts of interest.
Release Date: 05/24/2006
Upon completion of this Cyberounds®, you should be able to:
Describe the new classification of diabetes
Discuss the pathogenesis of Type 1 diabetes
Identify individuals with Type 1 diabetes using clinical and laboratory parameters.
